These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8923099)

  • 1. Trihexyphenidyl (Artane) abuse in schizophrenic patients.
    Zemishlany Z; Aizenberg D; Weiner Z; Weizman A
    Int Clin Psychopharmacol; 1996 Sep; 11(3):199-202. PubMed ID: 8923099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?
    Fisch RZ
    Acta Psychiatr Scand; 1987 Jan; 75(1):91-4. PubMed ID: 3577845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trihexyphenidyl (Artane) dependence: A controlled investigation between users and abusers.
    Qureshi NA; Al Amri AH; Abdelgadir MH; El-Haraka EA
    Ann Saudi Med; 1997 Mar; 17(2):185-90. PubMed ID: 17377427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse in first-episode schizophrenic patients: a retrospective study.
    Mauri MC; Volonteri LS; De Gaspari IF; Colasanti A; Brambilla MA; Cerruti L
    Clin Pract Epidemiol Ment Health; 2006 Mar; 2():4. PubMed ID: 16556300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trihexyphenidyl abuse in schizophrenic patient: a case report.
    Lo Y; Tsai SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):157-60. PubMed ID: 8634932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trihexyphenidyl (Artane): a Brazilian study of its abuse.
    Nappo SA; de Oliveira LG; Sanchez Zv; Carlini Ede A
    Subst Use Misuse; 2005; 40(4):473-82. PubMed ID: 15830730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia.
    Heinik J
    Int Psychogeriatr; 1998 Mar; 10(1):103-8. PubMed ID: 9629529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of benzhexol abuse.
    Crawshaw JA; Mullen PE
    Br J Psychiatry; 1984 Sep; 145():300-3. PubMed ID: 6478124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variety of effects of trihexyphenidyl (THP) on schizophrenic and non-schizophrenic abusers.
    Tandon R; Greden J
    Acta Psychiatr Scand; 1987 Dec; 76(6):732. PubMed ID: 3442265
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug abuse among patients requiring psychiatric hospitalization].
    Katz G; Shufman E; Knobler HY; Joffe M; Bar-Hamburger R; Durst R
    Harefuah; 2000 Jun; 138(12):1015-8, 1088. PubMed ID: 10979421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.
    Rosenthal RN; Hellerstein DJ; Miner CR
    Psychiatr Q; 1992; 63(1):3-26. PubMed ID: 1438603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Misuse of trihexyphenidyl (Artane, Parkinane): recent trends].
    Frauger E; Thirion X; Chanut C; Natali F; Debruyne D; Saillard C; Pradel V; Reggio P; Micallef J
    Therapie; 2003; 58(6):541-7. PubMed ID: 15058500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misuse of Trihexyphenidyl (Artane) on Réunion Island.
    Torrents R; Ferré JF; Konareff A; Hemery P; Sherwin K; Lassalle C; Simon N; Scerra S
    J Clin Psychopharmacol; 2018 Jun; 38(3):250-253. PubMed ID: 29620695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
    Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
    Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of violent behavior among acute psychiatric patients: clinical study.
    Amore M; Menchetti M; Tonti C; Scarlatti F; Lundgren E; Esposito W; Berardi D
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gradual withdrawal of long-term anticholinergic antiparkinson medication in Chinese patients with chronic schizophrenia.
    Ungvari GS; Chiu HF; Lam LC; Pang AH; Chung DW; Li SW; Chiu SN; Lum FC; Leung T
    J Clin Psychopharmacol; 1999 Apr; 19(2):141-8. PubMed ID: 10211915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.